by Sam P.K. Collins Posted on February 11, 2015
In one case of research misconduct, a report stated that all patients saw improvements in their condition when, in fact, one person had a foot amputation
by Sam P.K. Collins Posted on December 10, 2014
Amid a national opioid addiction epidemic, this study shows a changing tide among a group that has historically enjoyed a profitable relationship with pharmaceutical companies.
by Sam P.K. Collins Posted on November 5, 2014
“The World Health Organization has been trying to make this issue visible for ages. Now people can see for themselves.”
by Sam P.K. Collins Posted on October 24, 2014
"These issues don't really exist in any of the other countries we looked at. They all have universal health insurance. "
by Sam P.K. Collins Posted on October 23, 2014
It's a dynamic that's been on full display during the recent Ebola outbreak.
by Sam P.K. Collins Posted on October 9, 2014
Generic drugs are supposed to make it easier for Americans to afford their medication.
by Sam P.K. Collins Posted on October 1, 2014
There's now a public database revealing the speaking fees, consulting fees, and stake ownership of more than 500,000 physicians.
by Tara Culp-Ressler Posted on September 16, 2014
The company that manufacturers a breakthrough Hepatitis C treatment is allowing some generic versions to enter the market.
by Tara Culp-Ressler Posted on August 27, 2014
The ongoing lack of diversity is ultimately undermining our ability to develop better health treatments.
by Sam P.K. Collins Posted on August 15, 2014
A new study has prompted calls for the federal government to strengthen its drug approval process.